These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24559946)

  • 21. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices.
    Herweg B; Ilercil A; Kristof-Kuteyeva O; Rinde-Hoffman D; Caldeira C; Mangar D; Karlnosky R; Barold SS
    Pacing Clin Electrophysiol; 2012 Nov; 35(11):1377-83. PubMed ID: 22946711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.
    Moss AJ; Greenberg H; Case RB; Zareba W; Hall WJ; Brown MW; Daubert JP; McNitt S; Andrews ML; Elkin AD;
    Circulation; 2004 Dec; 110(25):3760-5. PubMed ID: 15583079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous-flow devices and percutaneous site infections: clinical outcomes.
    Goldstein DJ; Naftel D; Holman W; Bellumkonda L; Pamboukian SV; Pagani FD; Kirklin J
    J Heart Lung Transplant; 2012 Nov; 31(11):1151-7. PubMed ID: 22766022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads.
    Ambardekar AV; Lowery CM; Allen LA; Cannon AP; Cleveland JC; Lindenfeld J; Brieke A; Sauer WH
    J Card Fail; 2010 Apr; 16(4):327-31. PubMed ID: 20350700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis.
    Theuns DA; Thornton AS; Klootwijk AP; Scholten MF; Vantrimpont PJ; Balk AH; Jordaens LJ
    Eur J Heart Fail; 2005 Oct; 7(6):1027-32. PubMed ID: 16109500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of the implantable cardioverter-defibrillator in patients on the waiting list for heart transplantation].
    Podczeck A; Hief C; Jakl G; Frohner K; Nürnberg M; Kaltenbrunner W; Veit F; Laufer G; Steinbach K
    Wien Klin Wochenschr; 1995; 107(16):485-8. PubMed ID: 7571642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis.
    Naruse Y; Sekiguchi Y; Nogami A; Okada H; Yamauchi Y; Machino T; Kuroki K; Ito Y; Yamasaki H; Igarashi M; Tada H; Nitta J; Xu D; Sato A; Aonuma K
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):407-13. PubMed ID: 24837644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep-disordered breathing in patients with implantable cardioverter-defibrillator.
    Grimm W; Apelt S; Timmesfeld N; Koehler U
    Europace; 2013 Apr; 15(4):515-22. PubMed ID: 23129543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular arrhythmias during left ventricular assist device support.
    Bedi M; Kormos R; Winowich S; McNamara DM; Mathier MA; Murali S
    Am J Cardiol; 2007 Apr; 99(8):1151-3. PubMed ID: 17437746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication.
    Lüsebrink U; Duncker D; Hess M; Heinrichs I; Gardiwal A; Oswald H; König T; Klein G
    Europace; 2013 Jun; 15(6):820-6. PubMed ID: 23325044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of aortic insufficiency in patients supported with continuous flow left ventricular assist devices.
    Soleimani B; Haouzi A; Manoskey A; Stephenson ER; El-Banayosy A; Pae WE
    ASAIO J; 2012; 58(4):326-9. PubMed ID: 22569164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
    Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.